We therefore used mouse and human-specific primers to assess the expression of CCL2 in tumor tissues and found that the ACC-Meso-1 tumor expressed much higher levels of CCL2 at the baseline (approximately 16,000-fold higher than MSTO211H) (Figure 6a). Here, CCL2 is linked to adrenal cortex carcinoma.